These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3024666)

  • 1. Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant.
    Christomanou H; Aignesberger A; Linke RP
    Biol Chem Hoppe Seyler; 1986 Sep; 367(9):879-90. PubMed ID: 3024666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of two forms of an activator protein for the enzymic sphingomyelin degradation from human Gaucher spleen.
    Christomanou H; Kleinschmidt T
    Biol Chem Hoppe Seyler; 1985 Mar; 366(3):245-56. PubMed ID: 4005041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
    Christomanou H
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saposin D: a sphingomyelinase activator.
    Morimoto S; Martin BM; Kishimoto Y; O'Brien JS
    Biochem Biophys Res Commun; 1988 Oct; 156(1):403-10. PubMed ID: 2845979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the multiple forms of Gaucher spleen sphingolipid activator protein 2.
    Paton BC; Poulos A
    Biochem J; 1988 Aug; 254(1):77-84. PubMed ID: 3178760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on a sphingolipid activator protein (SAP-2) in fibroblasts from patients with lysosomal storage diseases, including Niemann-Pick disease Type C.
    Fujibayashi S; Wenger DA
    Clin Chim Acta; 1985 Mar; 146(2-3):147-56. PubMed ID: 3921288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the activation of sphingomyelinase activity in Niemann-Pick type A, B, and C fibroblasts: enzymological differentiation of types A and B.
    Poulos A; Ranieri E; Shankaran P; Callahan JW
    Pediatr Res; 1984 Nov; 18(11):1088-93. PubMed ID: 6096798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete amino-acid sequence and carbohydrate content of the naturally occurring glucosylceramide activator protein (A1 activator) absent from a new human Gaucher disease variant.
    Kleinschmidt T; Christomanou H; Braunitzer G
    Biol Chem Hoppe Seyler; 1987 Dec; 368(12):1571-8. PubMed ID: 3442600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete amino-acid sequence of the naturally occurring A2 activator protein for enzymic sphingomyelin degradation: identity to the sulfatide activator protein (SAP-1).
    Kleinschmidt T; Christomanou H; Braunitzer G
    Biol Chem Hoppe Seyler; 1988 Dec; 369(12):1361-5. PubMed ID: 3242555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal amino-acid sequence of a sphingolipid activator protein missing in a new human Gaucher disease variant.
    Christomanou H; Kleinschmidt T; Braunitzer G
    Biol Chem Hoppe Seyler; 1987 Sep; 368(9):1193-6. PubMed ID: 3675870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evidence for a processing error in the biosynthesis of Gaucher activator in mucolipidosis disease types II and III.
    Ranieri E; Paton B; Poulos A
    Biochem J; 1986 Feb; 233(3):763-72. PubMed ID: 3518703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the activation of the enzymatic hydrolysis of sphingomyelin liposomes.
    Poulos A; Ranieri E; Shankaran P; Callahan JW
    Biochim Biophys Acta; 1984 Apr; 793(2):141-8. PubMed ID: 6712963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.
    Peters SP; Coyle P; Coffee CJ; Glew RH
    J Biol Chem; 1977 Jan; 252(2):563-73. PubMed ID: 13071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme activities and phospholipid storage patterns in brain and spleen samples from Niemann-Pick disease variants: a comparison of neuropathic and non-neuropathic forms.
    Besley GT; Elleder M
    J Inherit Metab Dis; 1986; 9(1):59-71. PubMed ID: 3014212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder.
    Christomanou H; Chabás A; Pámpols T; Guardiola A
    Klin Wochenschr; 1989 Oct; 67(19):999-1003. PubMed ID: 2615292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease.
    Aerts JM; Donker-Koopman WE; Brul S; Van Weely S; Sa Miranda MC; Barranger JA; Tager JM; Schram AW
    Biochem J; 1990 Jul; 269(1):93-100. PubMed ID: 2198026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cohydrolases in human spleen that stimulate glucosyl ceramide beta-glucosidase.
    Iyer SS; Berent SL; Radin NS
    Biochim Biophys Acta; 1983 Oct; 748(1):1-7. PubMed ID: 6615847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ radiation-inactivation size of fibroblast membrane-bound acid beta-glucosidase in Gaucher type 1, type 2 and type 3 disease.
    Choy FY; Woo M; Potier M
    Biochim Biophys Acta; 1986 Mar; 870(1):76-81. PubMed ID: 3947649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.
    Ginns EI; Brady RO; Pirruccello S; Moore C; Sorrell S; Furbish FS; Murray GJ; Tager J; Barranger JA
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5607-10. PubMed ID: 6957882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological evidence for deficiency in an activator protein for sulfatide sulfatase in a variant form of metachromatic leukodystrophy.
    Inui K; Emmett M; Wenger DA
    Proc Natl Acad Sci U S A; 1983 May; 80(10):3074-7. PubMed ID: 6134282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.